-
EP3932409
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3932409
| EP3932409 - COMPOUNDS FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS CAUSED BY CORONAVIRUSES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.11.2022 Database last updated on 05.07.2024 | |
| Former | The application has been published Status updated on 03.12.2021 | Most recent event Tooltip | 11.11.2022 | Application deemed to be withdrawn | published on 14.12.2022 [2022/50] | Applicant(s) | For all designated states Consejo Superior de Investigaciones Científicas (CSIC) C/ Serrano 117 28006 Madrid / ES | For all designated states Universitat de València Avda. Blasco Ibáñez, 13 46010 Valencia / ES | For all designated states Universitat Politècnica de València Servicio de Promoción y Apoyo a Investigación Innovación y Transferencia i2T Camí de Vera, s/n Edificio 8G - Acceso A - Planta 3 46022 Valencia / ES | [2022/01] | Inventor(s) | 01 /
BENLLOCH BAVIERA, Jose María 46022 Valencia / ES | 02 /
GÁLVEZ LLOMPART, María 46022 Valencia / ES | 03 /
GÁLVEZ ALVAREZ, Jorge 46010 Valencia / ES | 04 /
ZANNI, Riccardo 46010 Valencia / ES | [2022/01] | Representative(s) | Pons Glorieta Rubén Darío 4 28010 Madrid / ES | [2022/01] | Application number, filing date | 20382570.8 | 29.06.2020 | [2022/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3932409 | Date: | 05.01.2022 | Language: | EN | [2022/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.11.2020 | Classification | IPC: | A61K31/546, A61K31/7048, A61P11/00, A61P31/14 | [2022/01] | CPC: |
A61K31/7048 (EP);
A61K31/546 (EP);
A61P11/00 (EP);
A61P31/14 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/01] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERBINDUNGEN ZUR BEHANDLUNG UND VORBEUGUNG VON DURCH CORONAVIREN VERURSACHTEN VIRUSINFEKTIONEN | [2022/01] | English: | COMPOUNDS FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS CAUSED BY CORONAVIRUSES | [2022/01] | French: | COMPOSÉS POUR LE TRAITEMENT ET LA PRÉVENTION DES INFECTIONS VIRALES CAUSÉES PAR LES CORONAVIRUS | [2022/01] | Examination procedure | 06.07.2022 | Application deemed to be withdrawn, date of legal effect [2022/50] | 27.07.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2022/50] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.06.2022 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]US2006062762 (WOODWARD JOHN R [US]) [X] 1,5-9,13 * paragraph [0036]; claim 1 * [Y] 1-13; | [XY]WO2017151120 (EMERGING VIRAL THERAPEUTICS LTD [CN], et al) [X] 1,5-9,13 * paragraphs [0005] , [0028] - [0029]; claims 1-3 * [Y] 1-13; | [XY]CN107281210 (INST MATERIA MEDICA CAMS) [X] 1-3,5,9,10,13 * the whole document * [Y] 1-3,5,9,10,13; | [XY]CN105456283B (SUN YAT-SEN UNIV; MEIZHOU PEOPLE'S HOSPITAL) [X] 1,5-9,13 * claim 1 *[Y] 1-13; | [XY]US2018318328 (FATHI REZA [US], et al) [X] 1,5-9,13 * paragraphs [0079] , [ 171] - [0184] - [0202] * [Y] 1-13; | [Y]AU2020100641 (BALASUBRAMANIAM VAIDYANATHAN DR [AU], et al) [Y] 1-5,9-13 * the whole document *; | [Y]CN111297838 (NINGBO HEKANG BIOMEDICAL TECH CO LTD) [Y] 1-13 * the whole document * | by applicant | - WANG J., "Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study", J Chem Inf Model, (20200000), URL: https://doi.org/10.1021/acs.jcim.0c00179 | - GAUTRET PLAGIER JCPAROLA PHOANG VTMEDDEB L et al., "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", Int J Antimicrob Agents, URL: https://doi.org/10.1016/j.ijantimicag.2020.105949 | - ZANNI RGALVEZ-LLOMPART MGARCIA-DOMENECH RGALVEZ J., "Latest advances in molecular topology applications for drug discovery", Expert Opin Drug Discov, (20150000), vol. 10, no. 9, pages 945 - 957 | - WANG JLAND DONO KGALVEZ JZHAO W et al., "Molecular topology as novel strategy for discovery of drugs with ap lowering and anti-aggregation dual activities for Alzheimer's disease", PloS one, (20140000), vol. 9, no. 3 | - MCGONAGLE, D.O'DONELL, J. et al., "Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia", Lancet Rheumatol, (20200000), URL: https://doi.org/10.1016/S2665-9913(20)30121-1 | - TAY, M.Z.POH, C.M.RENIA, L. et al., "The trinity of COVID-19: immunity, inflammation and intervention", Nat Rev Immunol, (20200000), vol. 20, doi:10.1038/s41577-020-0311-8, pages 363 - 374, XP037153301 DOI: http://dx.doi.org/10.1038/s41577-020-0311-8 | - "alvaDesc: A Tool to Calculate and Analyze Molecular Descriptors and Fingerprints", MAURI A., Ecotoxicological QSARs, Humana, (20200000), pages 801 - 820 | - REED LJMUENCH H., "A simple method of estimating fifty percent endpoints", Am J Trop Med Hyg, (19380000), vol. 27, pages 493 - 497 | - CORMAN VM et al., "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR", Euro Surveill, (20200000), vol. 25, doi:10.2807/1560-7917.ES.2020.25.3.2000045, page 2431, XP055695049 DOI: http://dx.doi.org/10.2807/1560-7917.ES.2020.25.3.2000045 | - "A Duplex Real-Time RT-PCR Assay for Profiling Inhibitors of Four Dengue Serotypes", GONG EYSMETS AVERHEYEN NCLYNHENS MGUSTIN ELORY PKRAUS G., Antiviral Methods and Protocols, Humana Press, (20130000), pages 195 - 203 | - BARTOSCH BDUBUISSON JCOSSET F-L., "Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes", J Exp Med, (20030000), vol. 197, doi:10.1084/jem.20021756, pages 633 - 642, XP002563514 DOI: http://dx.doi.org/10.1084/jem.20021756 | - MINGORANCE LFRIESLAND MCOTO-LLERENA MPEREZ-DEL-PULGAR SBOIX LLOPEZ-OLIVA JMBRUIX JFORNS XGASTAMINZA P., "Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine", Antimicrobial Agents and Chemotherapy, (20140000), vol. 58, doi:10.1128/AAC.02619-14, pages 3451 - 3460, XP055164532 DOI: http://dx.doi.org/10.1128/AAC.02619-14 |